Latest Articles

Publication Date
Epigenetic Compound Library Screen Identifies Ibrutinib as an Inhibitor of Ovarian Clear Cell Carcinoma Viability.

Ovarian clear cell carcinoma (OCCC) is an endometriosis-associated ovarian cancer subtype. Somatic mutations in OCCC are reported in ARID1A, PIK3CA, and the TERT promoter (TERTp), as well as less commonly …

Published: April 10, 2026, midnight
Police detain man after reported gun incident at Farmington Walmart - newscentermaine.com

Police detain man after reported gun incident at Farmington Walmart newscentermaine.com

Published: April 9, 2026, 6:34 p.m.
Neoadjuvant Chemotherapy Followed by Radical Cytoreductive Surgery in Serous Endometrial Carcinoma With Inguinal Lymph Node Metastasis: A Case Report - Cureus

Neoadjuvant Chemotherapy Followed by Radical Cytoreductive Surgery in Serous Endometrial Carcinoma With Inguinal Lymph Node Metastasis: A Case Report Cureus

Published: April 9, 2026, 9:38 a.m.
The inclusion of sex and gender considerations and female representation in Nutrition and Dietetics journals: A comparison between 2012 and 2022.

Consideration of sex and gender in nutrition research is needed to inform best practice interventions and policy. It is unknown how nutrition and dietetic journals comply with sex and gender …

Published: April 9, 2026, midnight
Unusual presentation of endometriosis as a large tubo-ovarian abscess posing a diagnostic challenge.

Tubo-ovarian abscess (TOA) is a severe complication of pelvic inflammatory disease (PID), but it can also occur in women without prior PID or sexually transmitted infections. Recent studies suggest that …

Published: April 7, 2026, midnight
Malignant Transformation of Endometriosis: A Rare Case of Extrauterine Endometrial Stromal Sarcoma.

Endometrial stromal sarcoma (ESS) is an extremely uncommon uterine malignancy, and commonly arises from preexisting endometriosis. On rare occasions, ESS arises from extrauterine tissues and is known as extra-uterine ESS. …

Published: April 6, 2026, midnight
Single-Dose Bioequivalence Study of Elagolix Tablets 200 mg (Test Product) and Elagolix Tablets 200 mg (Reference Product) in Healthy Non-Pregnant, Non-Lactating Premenopausal Female Subjects Under Fasting Conditions.

Elagolix is a short-acting oral gonadotropin-releasing hormone antagonist utilized for treating endometriosis-associated pain by rapidly suppressing gonadotropins and estradiol. Although well characterized in Western populations, clinical data regarding its use …

Published: April 2, 2026, midnight
Thoracic endometriosis in an inoperable patient.

In this case report, we present a case of a woman in her 30s who was diagnosed with thoracic endometriosis presenting as a large pulmonary mass. Hormonal treatment progestin (synthetic …

Published: April 2, 2026, midnight
DKSH and Bayer Expand Strategic Healthcare Alliance to Revolutionize Thailand's Endometriosis Care - thereporter.asia

DKSH and Bayer Expand Strategic Healthcare Alliance to Revolutionize Thailand's Endometriosis Care thereporter.asia

Published: April 1, 2026, 6:33 p.m.
Report reveals what women’s health innovators get wrong about coverage - FemTech World

Report reveals what women’s health innovators get wrong about coverage FemTech World

Published: March 31, 2026, 11 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!